Zymeworks re­moves CFO; Gilead ex­tends Nurix deal

Plus, news about On­cono­va Ther­a­peu­tics, Trawsfyny­dd Ther­a­peu­tics, No­cion Ther­a­peu­tics, Gink­go Bioworks and Mod­u­lus Ther­a­peu­tics:

Zymeworks ousts CFO: The biotech dis­closed Mon­day …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER